Mirabegron extended-release tablets (Myrbetriq) : treatment of overactive bladder (OAB) with symptoms of urgency, urgency incontinence and urinary frequency

MLA

Canadian Agency for Drugs and Technologies in Health. Mirabegron extended-release tablets (Myrbetriq) : treatment of overactive bladder (OAB) with symptoms of urgency, urgency incontinence and urinary frequency. Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, [2015]

APA

Canadian Agency for Drugs and Technologies in Health. (2015). Mirabegron extended-release tablets (Myrbetriq) : treatment of overactive bladder (OAB) with symptoms of urgency, urgency incontinence and urinary frequency. Ottawa, ON : Canadian Agency for Drugs and Technologies in Health.

Chicago

Canadian Agency for Drugs and Technologies in Health. Mirabegron extended-release tablets (Myrbetriq) : treatment of overactive bladder (OAB) with symptoms of urgency, urgency incontinence and urinary frequency. Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, [2015]